Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Xenon Pharmaceuticals Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 290 | 2 | 315 | +27 |
| Shares | 100.2M | 4.18M | 101.1M | +5.07M (+5.3%) |
| Value | $5.80B | $242.9M | $6.10B | +$538.5M (+9.7%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (49)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (22)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Holocene Advisors, LP | 1,518,686 | $88.3M |
| Commodore Capital LP | 825,000 | $48.0M |
| MPM Oncology Impact Management LP | 588,706 | $34.2M |
| Sofinnova Investments, Inc. | 305,216 | $17.7M |
| Y-Intercept (Hong Kong) Ltd | 85,388 | $4.97M |
| Atika Capital Management LLC | 59,900 | $3.48M |
| LMR Partners LLP | 56,200 | $3.27M |
| Qube Research & Technologies Ltd | 44,044 | $2.56M |
| Calamos Advisors LLC | 30,374 | $1.77M |
| SummitTX Capital, L.P. | 26,186 | $1.52M |
| Sanders Morris Harris LLC | 21,500 | $1.25M |
| Neo Ivy Capital Management | 13,710 | $797.2K |
| Covalis Capital LLP | 10,000 | $581.5K |
| Longaeva Partners L.P. | 6,250 | $363.4K |
| DRW Securities, LLC | 5,461 | $317.6K |
| Seeds Investor LLC | 3,423 | $203.2K |
| Jane Street Group, LLC | 3,468 | $201.7K |
| Acadian Asset Management LLC | 677 | $39.0K |
| MAI Capital Management | 392 | $22.8K |
| Root Financial Partners, LLC | 40 | $2.33K |
| Golden State Equity Partners | 35 | $2.04K |
| Twin Peaks Wealth Advisors, LLC | 32 | $1.86K |
Not filed for Q2 2026 yet (2)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 4,175,982 | $242.9M |
| CWM, LLC | 510 | $29.7K |